Literature DB >> 15220413

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes.

Darius Moradpour1, Matthew J Evans, Rainer Gosert, Zhenghong Yuan, Hubert E Blum, Stephen P Goff, Brett D Lindenbach, Charles M Rice.   

Abstract

Hepatitis C virus (HCV) replicates its genome in a membrane-associated replication complex, composed of viral proteins, replicating RNA and altered cellular membranes. We describe here HCV replicons that allow the direct visualization of functional HCV replication complexes. Viable replicons selected from a library of Tn7-mediated random insertions in the coding sequence of nonstructural protein 5A (NS5A) allowed the identification of two sites near the NS5A C terminus that tolerated insertion of heterologous sequences. Replicons encoding green fluorescent protein (GFP) at these locations were only moderately impaired for HCV RNA replication. Expression of the NS5A-GFP fusion protein could be demonstrated by immunoblot, indicating that the GFP was retained during RNA replication and did not interfere with HCV polyprotein processing. More importantly, expression levels were robust enough to allow direct visualization of the fusion protein by fluorescence microscopy. NS5A-GFP appeared as brightly fluorescing dot-like structures in the cytoplasm. By confocal laser scanning microscopy, NS5A-GFP colocalized with other HCV nonstructural proteins and nascent viral RNA, indicating that the dot-like structures, identified as membranous webs by electron microscopy, represent functional HCV replication complexes. These findings reveal an unexpected flexibility of the C-terminal domain of NS5A and provide tools for studying the formation and turnover of HCV replication complexes in living cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220413      PMCID: PMC434129          DOI: 10.1128/JVI.78.14.7400-7409.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  A simple in vitro Tn7-based transposition system with low target site selectivity for genome and gene analysis.

Authors:  M C Biery; F J Stewart; A E Stellwagen; E A Raleigh; N L Craig
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

2.  The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein.

Authors:  T Hügle; F Fehrmann; E Bieck; M Kohara; H G Kräusslich; C M Rice; H E Blum; D Moradpour
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

Review 3.  Hepatitis C virus replicons: potential role for drug development.

Authors:  Ralf Bartenschlager
Journal:  Nat Rev Drug Discov       Date:  2002-11       Impact factor: 84.694

4.  Functional characterization of the human immunodeficiency virus type 1 genome by genetic footprinting.

Authors:  L C Laurent; M N Olsen; R A Crowley; H Savilahti; P O Brown
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines.

Authors:  B Wölk; D Sansonno; H G Kräusslich; F Dammacco; C M Rice; H E Blum; D Moradpour
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus.

Authors:  G A Smith; L W Enquist
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Authors:  T Pietschmann; V Lohmann; G Rutter; K Kurpanek; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.

Authors:  N Krieger; V Lohmann; R Bartenschlager
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

10.  The hepatitis C virus RNA-dependent RNA polymerase membrane insertion sequence is a transmembrane segment.

Authors:  Natalia Ivashkina; Benno Wölk; Volker Lohmann; Ralf Bartenschlager; Hubert E Blum; François Penin; Darius Moradpour
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

View more
  124 in total

1.  Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Authors:  Naushad Ali; Heba Allam; Randal May; Sripathi M Sureban; Michael S Bronze; Ted Bader; Shahid Umar; Srikant Anant; Courtney W Houchen
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

4.  A full-length cDNA infectious clone of North American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the Nsp2 region.

Authors:  Ying Fang; Raymond R R Rowland; Michael Roof; Joan K Lunney; Jane Christopher-Hennings; Eric A Nelson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

5.  Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.

Authors:  Tia S Deas; Iwona Binduga-Gajewska; Mark Tilgner; Ping Ren; David A Stein; Hong M Moulton; Patrick L Iversen; Elizabeth B Kauffman; Laura D Kramer; Pei-Yong Shi
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.

Authors:  Yongfang Jiang; Hui Bao; Yan Ge; Wei Tang; Du Cheng; Kaizhong Luo; Guozhong Gong; Rujun Gong
Journal:  Gut       Date:  2014-05-08       Impact factor: 23.059

8.  Endocytic Rab proteins are required for hepatitis C virus replication complex formation.

Authors:  David Manna; Jason Aligo; Chenjia Xu; Wei Sun Park; Hasan Koc; Won Do Heo; Kouacou V Konan
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

9.  Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.

Authors:  Guaniri Mateu; Ruben O Donis; Takaji Wakita; Jens Bukh; Arash Grakoui
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

10.  Systematic assembly of a full-length infectious clone of human coronavirus NL63.

Authors:  Eric F Donaldson; Boyd Yount; Amy C Sims; Susan Burkett; Raymond J Pickles; Ralph S Baric
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.